Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.76 |
| ▸ | TSHR | P16473 | 3/20 | 0.76 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.76 |
| ▸ | LMNA | P02545 | 2/20 | 0.76 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.76 |
| ▸ | ALB | P02768 | 1/20 | 0.76 |
| ▸ | FBP1 | P09467 | 6/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.61 |
| ▸ | HTR2A | P28223 | 1/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
| ▸ | DHFR | P00374 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 2/20 | 0.54 |
| ▸ | CA1 | P00915 | 2/20 | 0.54 |
| ▸ | CA2 | P00918 | 2/20 | 0.54 |
| ▸ | CA9 | Q16790 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carbutamide SCHEMBL49231 | 1.00 | ALDH1A1 (0.76) | ALDH1A1TSHRCYP2C9LMNATDP1 | |
| Carbutamide SCHEMBL7615910 | 0.91 | ALDH1A1 (0.78) | ALDH1A1TSHRCYP2C9LMNATDP1 | |
| Tolbutamide SCHEMBL15918 | 0.87 | ALDH1A1 (1.00) | ALDH1A1TSHRCYP2C9LMNATDP1 | |
| Tolbutamide SCHEMBL1536920 | 0.87 | ALDH1A1 (1.00) | ALDH1A1TSHRCYP2C9LMNATDP1 | |
| SCHEMBL11390868 | 0.86 | CYP2C9 (0.69) | ALDH1A1TSHRCYP2C9LMNATDP1 | |
| Carbutamide SCHEMBL7833740 | 0.86 | CYP2C9 (0.61) | ALDH1A1TSHRCYP2C9LMNATDP1 | |
| Tolbutamide SCHEMBL7551276 | 0.85 | ALDH1A1 (0.97) | ALDH1A1TSHRCYP2C9LMNATDP1 | |
| Tolbutamide SCHEMBL11357518 | 0.85 | ALDH1A1 (0.97) | ALDH1A1TSHRCYP2C9LMNATDP1 | |
| Tolbutamide SCHEMBL140363 | 0.85 | ALDH1A1 (0.97) | ALDH1A1TSHRCYP2C9LMNATDP1 | |
| Tolbutamide SCHEMBL4367531 | 0.85 | ALDH1A1 (0.97) | ALDH1A1TSHRCYP2C9LMNATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2046341-B1 | COMPOSITIONS AND METHODS FOR TREATING DIABETES AND NEUROPSYCHOLOGICAL DYSFUNCTION | Assistance Publique Hôpitaux De Paris (FR) | 2016-07-13 | — | — | EP | disclosed |
| US-20130184293-A1 | COMPOSITIONS AND METHODS FOR TREATING DIABETES AND NEUROPSYCHOLOGICAL DYSFUNCTION | UNIVERSITE PARIS DESCARTES (FR) | 2013-07-18 | — | — | US | disclosed |
| US-8354452-B2 | Compositions and methods for treating diabetes and neuropsychological dysfunction | ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (FR) | 2013-01-15 | — | — | US | disclosed |
| US-20090306212-A1 | Compositions and Methods for Treating Diabetes and Neuropsychological Dysfunction | ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (FR) | 2009-12-10 | — | — | US | disclosed |
| EP-2046341-A1 | COMPOSITIONS AND METHODS FOR TREATING DIABETES AND NEUROPSYCHOLOGICAL DYSFUNCTION | Assistance Publique - Hopitaux de Paris (FR) | 2009-04-15 | — | — | EP | disclosed |
| WO-2008015226-A1 | COMPOSITIONS AND METHODS FOR TREATING DIABETES AND NEUROPSYCHOLOGICAL DYSFUNCTION | ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS (FR) | 2008-02-07 | — | — | WO | disclosed |
| EP-1884244-A1 | Potassium channel ligands for treating diabetes and neuropsychological dysfunction | Assistance Publique - Hopitaux de Paris (FR) | 2008-02-06 | — | — | EP | disclosed |